Public company directors must remember whom they work for
Mushrooming management compensation, unconnected to performance, is an obvious area where directors have failed the people they legally represent. Investors for Director Accountability screened the largest 1,000 American corporations in order to pinpoint the most egregious disconnects. Qualitative judgments were then applied. Long story short: Investors for Director Accountability has concluded that shareholders should withhold their votes for the four nominees for the Pfizer Board of Directors who are members of the Board’s compensation committee. This would be a first step on a long road to restore director accountability to owners.
Continue reading "Public company directors must remember whom they work for" »